NCT01806467

Brief Summary

Many mini-invasive devices to monitor cardiac output (CO) have been introduced and among them the Pressure Recording Analytical Method (PRAM). The aim of this study is to assess the agreement of PRAM with the intermittent transpulmonary thermodilution (ThD) and continuous pulmonary ThD in measuring CO in hemodynamically unstable patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

February 26, 2013

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 7, 2013

Completed
Last Updated

March 7, 2013

Status Verified

March 1, 2013

Enrollment Period

8 months

First QC Date

February 26, 2013

Last Update Submit

March 6, 2013

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blant-Altman test and coefficient of error of Cardiac Output measured with PRAM towards that measured with thermodilution

    Agreement between Cardiac Output measured with PRAM and cardiac output measured with thermodilution (both pulmonary and transpulmonary thermodilution) was determined by the Bland-Altman method. The precision of the measurements was given by the limits of agreement (LoA) (±1.96SD) of the mean difference of the methods compared. Upper and lower LoA were calculated as the bias ± 1.96SD. The percentage error was calculated as the LoA of the bias divided by the mean CO from two methods compared. Thirty per cent was considered an a priori criterion of interchangeability.

    Study Period: 9 months

Study Arms (2)

critically ill patients

patients admitted to the medical-surgical ICU

post-cardiac surgical patients

patients admitted to the post-cardiac surgical ICU

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

hemodynamic instability

You may qualify if:

  • Hemodynamic instability in:
  • septic shock
  • pneumonia
  • polytrauma
  • chronic obstructive pulmonary disease
  • heart failure
  • post operative cardiosurgical patients

You may not qualify if:

  • Atrial fibrillation
  • Pacemaker or implantable cardiac defibrillator
  • Aortic or mitral valve disease
  • Intra-aortic balloon pump

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Ospedali Riuniti Ancona

Ancona, Ancona, 60126, Italy

Location

Study Officials

  • Abele Donati, MD

    UPollitecnicaDM

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 26, 2013

First Posted

March 7, 2013

Study Start

August 1, 2011

Primary Completion

April 1, 2012

Study Completion

May 1, 2012

Last Updated

March 7, 2013

Record last verified: 2013-03

Locations